The Analytical Core will serve as a collection and distribution point for blood and fecal samples, DNA, colorectal adenoma tissue blocks, and rectal mucosal samples. It will provide a resource and service for carrying our the laboratory analyses proposed in this application in support of the clinical trials. The Core will develop appropriate sample collection, tracking, storage, and preparation procedures for all human material collected during the course of this proposal. It will develop and optimize methods for measuring the secondary laboratory directed research endpoints to be used in evaluating the various trials to be conducted by the individual Projects in this proposal. The Analytical Core will be responsible for the collection, logging, processing, distribution, and tracking of all tissues and samples. Endpoints to be analyzed by the Analytical Core will include blood levels of treatment drug and fecal primary and secondary bile acid concentrations. In addition, the core will be responsible for analyzing genetic polymorphisms, molecular genetic and epigenetic markers (CIMP status, Ki-ras, p53, APC), and CIMP and COX expression in DNA, archival tissue blocks and rectal mucosal biopsies. The Analytical Core will analyze nuclear chromatin texture alterations in rectal biopsies and cell proliferation measured by labeling indices using PCNA as well as apoptosis by in situ TUNEL and morphology in archival colorectal adenomas. The Analytical Core will oversee and coordinate the collection and processing of all samples related to this Program Project at the various participating hospitals and clinics. In addition, the Analytical Core will be responsible for the training of personnel involved in the collection and processing of study samples. It will perform actual assays and will work closely with the Biometry ore to provide data for reporting and interpretation. Quality assurance and quality control procedures will continue to be developed by the Analytical Core which will be supervised by the Biometry Core for sample acquisition, processing, and analysis procedures included in each of the clinical projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA041108-15
Application #
6481192
Study Section
Project Start
2001-08-01
Project End
2002-07-31
Budget Start
Budget End
Support Year
15
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85722
Lance, Peter; Alberts, David S; Thompson, Patricia A et al. (2017) Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention. Cancer Prev Res (Phila) 10:45-54
Thompson, Patricia A; Ashbeck, Erin L; Roe, Denise J et al. (2016) Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. J Natl Cancer Inst 108:
Jacobs, Elizabeth T; Haussler, Mark R; Alberts, David S et al. (2016) Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations. Cancer Prev Res (Phila) 9:589-97
Liu, Lin; Messer, Karen; Baron, John A et al. (2016) A prognostic model for advanced colorectal neoplasia recurrence. Cancer Causes Control 27:1175-85
Thompson, Patricia A; Ashbeck, Erin L; Roe, Denise J et al. (2016) Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. J Natl Cancer Inst 108:
Hibler, Elizabeth A; Sardo Molmenti, Christine L; Dai, Qi et al. (2016) Physical activity, sedentary behavior, and vitamin D metabolites. Bone 83:248-255
Hibler, Elizabeth A; Klimentidis, Yann C; Jurutka, Peter W et al. (2015) CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence. Nutr Cancer 67:1131-41
Minasian, Lori M; Tangen, Catherine M; Wickerham, D Lawrence (2015) Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program. Semin Oncol 42:748-63
Bea, Jennifer W; Jurutka, Peter W; Hibler, Elizabeth A et al. (2015) Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components. Metabolism 64:447-59
Molmenti, Christine L Sardo; Hibler, Elizabeth A; Ashbeck, Erin L et al. (2014) Sedentary behavior is associated with colorectal adenoma recurrence in men. Cancer Causes Control 25:1387-95

Showing the most recent 10 out of 149 publications